Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials Post author: Post published: November 13, 2023 Post category:uncategorized A prospective path for allogeneic cellular immunotherapies. You Might Also Like Study: Early advanced therapy significantly improves Crohn’s disease outcomes February 22, 2024 Monolithic photocurable hyaluronic acid patch achieves strong wet adhesion for durotomy repair January 16, 2026 Rush earns top national ranking for high-quality academic patient care September 25, 2026
Monolithic photocurable hyaluronic acid patch achieves strong wet adhesion for durotomy repair January 16, 2026